Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis

Stem Cells

Volumn 32, Issue 2, 2014, Pages 349-363

  Yu, Yong ^a   Liang, Dan ^a   Tian, Qing ^a   Chen, Xiaona ^a   Jiang, Bo ^a   Chou, Bin Kuan ^b,c   Hu, Ping ^a   Cheng, Linzhao ^b,c   Gao, Ping ^c,d   Li, Jinsong ^a   Wang, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Akt; ERas; FoxO1; Induced pluripotent stem cells; Reprogramming

Indexed keywords

AKT; ERAS; FOXO1; INDUCED PLURIPOTENT STEM CELLS; REPROGRAMMING;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEOPLASMS; NUCLEAR REPROGRAMMING; ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84894514196     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1447     Document Type: Article

References (76)

1. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321: 699-702.
2. Eminli S, Utikal J, Arnold K et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008;26: 2467-2474.
3. Hanna J, Markoulaki S, Schorderet P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008;133: 250-264.
4. Maherali N, Ahfeldt T, Rigamonti A et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008;3: 340-345.
5. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 2008;18: 890-894.
6. Wernig M, Lengner CJ, Hanna J et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008;26: 916-924.
7. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131: 861-872.
8. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
9. Li WL, Wei W, Zhu SY et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009; 4: 16-19.
10. Liao J, Cui C, Chen SY et al. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 2009;4: 11-15.
11. Liu HS, Zhu FF, Yong J et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 2008;3: 587-590.
12. Esteban MA, Xu J, Yang J et al. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem 2009;284: 17634-17640.
13. Wu Z, Chen J, Ren J et al. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 2009;1: 46-54.
14. Chen JK, Liu J, Yang JQ et al. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 2010;21: 205-212.
15. Esteban MA, Wang T, Qin B et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2009;6: 71-79.
16. Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 2009;5: 491-503.
17. Marson A, Foreman R, Chevalier B et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008;3: 132-135.
18. Shi Y, Desponts C, Do JT et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by oct4 and klf4 with smallmolecule compounds. Cell Stem Cell 2008;3: 568-574.
19. Shi Y, Do JT, Desponts C et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;2: 525-528.
20. Zhao Y, Yin X, Qin H et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008; 3: 475-479.
21. Huangfu D, Maehr R, Guo W et al. Induction of pluripotent stem cells by defined factors is greatly improved by smallmolecule compounds. Nat Biotechnol 2008; 26: 795-797.
22. Samavarchi-Tehrani P, Golipour A, David L et al. Functional genomics reveals a bmpdriven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010;7: 64-77.
23. Choi YJ, Lin CP, Ho JJ et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011;13: 1353-1360.
24. Feng B, Jiang J, Kraus P et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009;11: 197-203.
25. Heng JC, Feng B, Han J et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010;6: 167-174.
26. Maherali N, Hochedlinger K. Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 2009;19: 1718-1723.
27. Silva J, Barrandon O, Nichols J et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 2008;6: 2237-2247.
28. Hong H, Takahashi K, Ichisaka T et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460: 1132-1135.
29. Kawamura T, Suzuki J, Wang YV et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460: 1140-1144.
30. Marion RM, Strati K, Li H et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009;460: 1149-1153.
31. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009;460: 49-52.
32. Hanna J, Saha K, Pando B et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009;462: 595-601.
33. Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 2003; 423: 541-545.
34. Takahashi K, Murakami M, Yamanaka S. Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem Soc Trans 2005;33: 1522-1525.
35. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126: 663-676.
36. Blelloch R, Venere M, Yen J et al. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007;1: 245-247.
37. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007;25: 1177-1181.
38. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448: 313-317.
39. Storm MP, Bone HK, Beck CG et al. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem 2007;282: 6265-6273.
40. Kimura T, Tomooka M, Yamano N et al. AKT signaling promotes derivation of embry-onic germ cells from primordial germ cells. Development 2008;135: 869-879.
41. Nakamura T, Inoue K, Ogawa S et al. Effects of Akt signaling on nuclear reprogramming. Genes Cells 2008;13: 1269-1277.
42. Sekine K, Chen YR, Kojima N et al. Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development. EMBO J 2007;26: 3607-3615.
43. Qin DJ, Gan Y, Shao KF et al. Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors. J Biol Chem 2008;283: 33730-33735.
44. Wang W, Huang L, Huang Y et al. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev Cell 2009;16: 764-771.
45. Mali P, Ye Z, Chou BK et al. An improved method for generating and identifying human induced pluripotent stem cells. Methods Mol Biol (Clifton, Nj) 2010;636: 191-205.
46. Brambrink T, Foreman R, Welstead GG et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008;2: 151-159.
47. Stadtfeld M, Maherali N, Breault DT et al. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008;2: 230-240.
48. Polo JM, Anderssen E, Walsh RM et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012;151: 1617-1632.
49. Liu L, Rao JN, Zou T et al. c-Myc inhibits Akt kinase activity and increases susceptibility to apoptosis in normal intestinal epithelial cells. Gastroenterology 2005;128: A515-A515.
50. Bellmann K, Martel J, Poirier DJ et al. Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc. Apoptosis 2006;11: 1311-1319.
51. Zhao R, Zhao ZJ. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling. Biochem J 1999; 338(Pt 1): 35-39.
52. Li Z, Rana TM. A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation. Nat Commun 2012;3: 1085.
53. Takahashi K, Nakagawa M, Young SG et al. Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway. J Biol Chem 2005;280: 32768-32774.
54. Franke TF, Yang SI, Chan TO et al. The protein-kinase encoded by the Akt protooncogene is a target of the Pdgf-activated phosphatidylinositol 3-kinase. Cell 1995;81: 727-736.
55. Cully M, You H, Levine AJ et al. Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006;6: 184-192.
56. Tzivion G, Hay N. PI3K-AKT-FoxO axis in cancer and aging. Biochim Biophys Acta 2011;1813: 1925.
57. Zhang X, Yalcin S, Lee DF et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol 2011;13: 1092-1099.
58. Paik JH, Kollipara R, Chu G et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007;128: 309-323.
59. Sykes SM, Lane SW, Bullinger L et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 2011;146: 697-708.
60. Tran H, Brunet A, Griffith EC et al. The many forks in FOXO's road. Sci STKE 2003; 2003: RE5.
61. Ying QL, Nichols J, Chambers I et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003;115: 281-292.
62. Li H, Collado M, Villasante A et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009;460: 1136-1139.
63. Utikal J, Polo JM, Stadtfeld M et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009;460: 1145-1148.
64. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009;324: 1029-1033.
65. Folmes CD, Nelson TJ, Martinez-Fernandez A et al. Somatic oxidative bioenergetics transitions into pluripotencydependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011;14: 264-271.
66. Zhu S, Li W, Zhou H et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010;7: 651-655.
67. Krizhanovsky V, Lowe SW. Stem cells: The promises and perils of p53. Nature 2009; 460: 1085-1086.
68. Tong M, Lv Z, Liu L et al. Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesis. Cell Res 2011;21: 1634-1637.
69. Kameda T, Thomson JA. Human ERas gene has an upstream premature polyadenylation signal that results in a truncated, noncoding transcript. Stem Cells 2005;23: 1535-1540.
70. Aoyama M, Kataoka H, Kubota E et al. Resistance to chemotherapeutic agents and promotion of transforming activity mediated by embryonic stem cell-expressed Ras (ERas) signal in neuroblastoma cells. Int J Oncol 2010;37: 1011-1016.
71. Kaizaki R, Yashiro M, Shinto O et al. Expression of ERas oncogene in gastric carcinoma. Anticancer Res 2009;29: 2189-2193.
72. Kubota E, Kataoka H, Aoyama M et al. Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer. Am J Pathol 2010;177: 955-963.
73. Zhang J, He XC, Tong WG et al. Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion. Stem Cells 2006;24: 2826-2839.
74. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010;327: 542-545.
75. He XC, Yin T, Grindley JC et al. PTENdeficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007;39: 189-198.
76. Efe JA, Hilcove S, Kim J et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 2011;13: 215-222.